Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PK, PD, and Safety”

Showing 7 of 0 results

Early research (Phase 1)Study completedNCT04045405
What this trial is testing

Clinical Study to Assess Safety, PK and PD Parameters of CDR132L

Who this might be right for
Heart Failure
Cardior Pharmaceuticals GmbH 28
Early research (Phase 1)Study completedNCT05282914
What this trial is testing

Compare PK, PD and Safety of UI058 and UIC202004 in Healthy Subjects

Who this might be right for
GERD
Korea United Pharm. Inc. 41
Early research (Phase 1)Study completedNCT03558477
What this trial is testing

PK/PD Clinical Trial of YYD601 in Healthy Adult Male

Who this might be right for
GERD
Yooyoung Pharmaceutical Co., Ltd. 30
Early research (Phase 1)Study completedNCT04802967
What this trial is testing

A Study on Ketoprofen Lysine Salt (KLS) + Gabapentin (GABA) vs KLS to Investigate Their Pharmacodynamic in Healthy Males

Who this might be right for
No Condition
Dompé Farmaceutici S.p.A 141
Testing effectiveness (Phase 2)Study completedNCT04135495
What this trial is testing

Evaluate the Safety, Tolerability, PK and PD of ELX-02 in Cystic Fibrosis Patients With G542X Allele

Who this might be right for
Cystic Fibrosis
Eloxx Pharmaceuticals, Inc. 17
Testing effectiveness (Phase 2)Study completedNCT02124772
What this trial is testing

Study to Investigate Safety, Pharmacokinetic (PK), Pharmacodynamic (PD) and Clinical Activity of Trametinib in Subjects With Cancer or Plexiform Neurofibromas and Trametinib in Combination With Dabrafenib in Subjects With Cancers Harboring V600 Mutations

Who this might be right for
Cancer
Novartis Pharmaceuticals 139
Testing effectiveness (Phase 2)Study completedNCT00924534
What this trial is testing

A Safety PK/PD Study of SLV337 in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Abbott Products 61

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation